Boston Scientific (BSX) May option implied volatility into quarter results

Go back to Boston Scientific (BSX) May option implied volatility into quarter results

Boston Scientific (BSX) PT Raised to $77 at Oppenheimer

April 25, 2024 10:00 AM EDT

Oppenheimer analyst Steven Lichtman raised the price target on Boston Scientific (NYSE: BSX) to $77.00 (from $68.00) while maintaining a Outperform rating.

The analyst comments "BSX delivered 1Q24 sales meaningfully ahead of the Street (13% organic y/y). EPS was also beat ($0.56 versus our/Street's... More

Boston Scientific (BSX) PT Raised to $82 at Wells Fargo

April 25, 2024 5:23 AM EDT

Wells Fargo analyst Lawrence Biegelsen raised the price target on Boston Scientific (NYSE: BSX) to $82.00 (from $72.00) while maintaining a Overweight rating.

The analyst comments "Today (4/24), BSX reported Q1 rev/EPS ahead of Street and raised 2024 rev guidance by 250bps at the mdpt to 10-12%.... More

Boston Scientific (BSX) PT Raised to $80 at BTIG

April 24, 2024 3:14 PM EDT

BTIG analyst Marie Thibault raised the price target on Boston Scientific (NYSE: BSX) to $80.00 (from $74.00) while maintaining a Buy rating.

The analyst comments "After a record-setting 2023, Boston Scientific is starting 2024 at an even faster pace. BSX reported Q1 revenue of $3.856B (+13.8% y/y rep., +13.1% org.) and adj. EPS of $0.56 (consensus $3.684B and $0.51), well above its guidance... More